Cullen/Frost Bankers has emerged from its July 30 Q2 earnings release with a wave of upward analyst revisions, yet the stock at $168.26 trades fractionally below the newly raised consensus target — a narrower gap than existed heading into the print, and the key tension worth watching now.
The Street response to the Q2 results has been unusually uniform in direction. Five firms raised price targets in the days immediately following the release. Evercore ISI lifted to $181 while maintaining its In-Line rating. TD Cowen moved to $185, keeping its Buy. Stephens & Co. raised to $183 on an Overweight. Keefe, Bruyette & Woods went to $175 on Outperform. RBC Capital moved to $176 on Sector Perform. Every move was upward. The mean target now sits at $168.93 — essentially at the current price, which means bulls and cautious holders are reading from the same page even as their ratings differ. The earnings reaction itself was muted: the stock fell 0.35% on July 30, suggesting the results met but did not meaningfully exceed expectations.
The bull case rests on CFR's relationship-banking model in Texas, continued loan and deposit growth, and management's raised earnings guidance. EPS momentum ranks in the 87th percentile on a 30-day basis and the 80th on 90 days — the company has been consistently beating near-term estimates. The bear case is more structural: heavy reliance on Texas commercial clients leaves the bank exposed to any regional economic slowdown, and the margin sensitivity to Fed rate cuts remains a live risk. The dividend score ranks in the 96th percentile, which keeps income-focused holders anchored even when the growth story softens. Forward P/E has expanded to 14.7x over the past month, up about 0.44 turns in 30 days, reflecting the post-earnings re-rating.
The lending market tells a notably relaxed story — one that has actually loosened further since the pre-earnings note. Availability now runs at 567%, up from roughly 579% the prior week and well above the 52-week tightest reading near 489% hit on July 30. Cost to borrow remains negligible at 0.54%, up about 3% on the week but still firmly in low territory. Short interest at 6% of the free float edged down about 0.7% on the week after a month that saw a modest 1% net build. The ORTEX short score has drifted lower — from 53.4 on July 24 to 51.9 today — consistent with waning short conviction post-earnings. Options positioning is skewed heavily toward calls: the put/call ratio of 0.12 sits nearly a standard deviation below its 20-day average of 0.15, reinforcing that options traders remain constructive rather than defensive.
Among peers, the week was broadly positive for the group but CFR's 0.7% gain lagged SSB's 2.7% and BOKF's 1.6%. UBSI, FULT, and AUB all finished roughly flat to slightly positive. The relative underperformance is modest, but worth flagging given that CFR's Q2 beat triggered the most concentrated cluster of target raises in the peer group this week. BlackRock remains the largest holder at 11.4% of shares and added about 111,000 shares through June 30, the most recent institutional snapshot available.
With no next earnings event yet scheduled and the stock essentially pinned at consensus, the debate shifts from whether CFR can deliver to whether the Texas franchise can sustain its growth cadence — and how quickly the Fed's rate path reshapes the margin outlook.
See the live data behind this article on ORTEX.
Open CFR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
